基于“和解少阳”理论探讨小柴胡颗粒联合 泮托拉唑治疗胃食管反流病的疗效观察
Observation on the Efficacy of Xiaochaihu Granules Combined with Pantoprazole in the Treatment of Gastroesophageal Reflux Disease Based on the Theory of “Relieving Shaoyang Disorder”
DOI: 10.12677/acm.2026.1651987, PDF,   
作者: 龙立芬:贵州省天柱县中医医院西药房,贵州 黔东南
关键词: 胃食管反流病小柴胡颗粒泮托拉唑Gastroesophageal Reflux Disease Xiaochaihu Granules Pantoprazole
摘要: 目的:基于“和解少阳”理论观察小柴胡颗粒联合泮托拉唑治疗胃食管反流病的临床疗效。方法:选取2023年09月至2025年09月于天柱县中医医院治疗64例胃食管反流病患者,按照随机数字法分为2组,对照组32例以泮托拉唑口服,治疗组32例在对照组基础上予小柴胡颗粒口服,2组疗程均为12周。对比两组患者治疗前后的中医证候积分、食管黏膜损伤评分及临床疗效。结果:治疗12周后,两组中医证候积分、食管黏膜损伤评分均改善,且治疗组优于对照组,差异有统计学意义(P < 0.05)。结论:小柴胡颗粒联合泮托拉唑可有效缓解胃食管反流病患者的临床症状,减轻食管黏膜损伤,提高生活质量,以“和解少阳”立论的小柴胡颗粒符合胃食管反流病病机病证。
Abstract: Objective: To observe the clinical efficacy of Xiaochaihu Granules combined with pantoprazole in treating gastroesophageal reflux disease (GERD) based on the theory of “relieving shaoyang disorder”. Methods: A total of 64 GERD patients treated at Tianzhu County Hospital of Traditional Chinese Medicine from September 2023 to September 2025 were enrolled and randomly divided into two groups using a random number method. The control group (n = 32) received oral pantoprazole, while the treatment group (n = 32) received oral Xiaochaihu Granules in addition to pantoprazole. Both groups underwent a 12-week treatment course. The Traditional Chinese Medicine syndrome scores, esophageal mucosal injury scores, and clinical efficacy were compared before and after treatment. Results: After 12 weeks of treatment, both groups showed improvement in Traditional Chinese Medicine syndrome scores and esophageal mucosal injury scores, with the treatment group demonstrating superior outcomes compared to the control group (P < 0.05). Conclusion: Xiaochaihu Granules combined with pantoprazole can effectively alleviate clinical symptoms of GERD patients, reduce esophageal mucosal injury, and improve quality of life. The therapeutic principle of “relieving shaoyang disorder” in Xiaochaihu Granules aligns with the pathogenesis and clinical manifestations of GERD.
文章引用:龙立芬. 基于“和解少阳”理论探讨小柴胡颗粒联合 泮托拉唑治疗胃食管反流病的疗效观察[J]. 临床医学进展, 2026, 16(5): 1835-1842. https://doi.org/10.12677/acm.2026.1651987

参考文献

[1] 邵燕婷, 徐亭亭. 抑郁与胃食管反流病相关表型的遗传关联性分析[J]. 南京医科大学学报(自然科学版), 2026, 46(1): 112-122.
[2] 鲜印, 袁玲, 田洪旭, 等. 胃食管反流病与耳聋耳鸣因果关系的孟德尔随机化研究[J]. 中华耳科学杂志, 2026, 24(1): 38-45.
[3] 冯彬彬, 王天麟, 韩俊泉, 等. 胃食管反流病和胰腺炎的因果关联: 孟德尔随机化研究和共定位分析[J]. 胃肠病学和肝病学杂志, 2026, 35(1): 82-88.
[4] 李修业, 方向明. 胃食管反流病影响因素及相关机制研究进展[J]. 胃肠病学和肝病学杂志, 2025, 34(3): 420-423.
[5] 刘凤, 艾玉婷, 毛晓霞, 等. 四逆和胃方联合三联疗法对幽门螺杆菌阳性胃食管反流病患者内脏高敏感、胃肠激素分泌紊乱的调节效果[J]. 中华中医药学刊, 2025, 43(5): 52-56.
[6] 刘杨, 薛小娜, 吕亚楠, 等. 观察针刀联合和胃降气汤对难治性胃食管反流病患者疗效的影响[J]. 辽宁中医杂志, 2025, 52(1): 139-143.
[7] 张双圆, 陈含情, 李军祥, 等. 和胃降逆方治疗非糜烂性胃食管反流病寒热错杂证的临床研究[J]. 北京中医药大学学报, 2025, 48(8): 1107-1114.
[8] 中华医学会消化病学分会胃肠动力学组, 中华医学会消化病学分会胃肠功能性疾病协作组, 中华医学会消化病学分会食管疾病协作组, 等. 中国胃食管反流病诊疗规范[J]. 胃肠病学, 2023, 28(10): 597-607.
[9] 中华中医药学会脾胃病分会. 胃食管反流病中医诊疗专家共识(2023) [J]. 中医杂志, 2023, 64(18): 1935-1944.
[10] 中国中西医结合学会消化系统疾病专业委员会, 唐艳萍, 时昭红, 等. 胃食管反流病中西医结合诊疗专家共识(2025年) [J]. 中国中西医结合消化杂志, 2025, 33(3): 217-229.
[11] 马乾章, 刘国政, 孙美仑, 等. 中药消补汤治疗非糜烂性胃食管反流病临床疗效[J]. 辽宁中医杂志, 2024, 51(1): 118-121.
[12] 沈洪, 胡静怡, 朱磊, 等. 提高胃食管反流病临床疗效的中西医策略[J]. 江苏中医药, 2024, 56(2): 1-6.
[13] 韩丽丽, 武朝阳, 马小丽, 等. 肝郁论治下柴胡配伍在胃食管反流病伴焦虑抑郁中的应用[J]. 长春中医药大学学报, 2026, 42(1): 118-125.
[14] 李宗选. 胃食管反流病治疗的研究进展[J]. 中外医学研究, 2025, 23(19): 180-184.
[15] 中华消化心身联盟. 多巴胺D2受体拮抗剂消化专科合理应用中国专家意见[J]. 胃肠病学, 2020, 25(11): 673-677.
[16] 胡嘉琳. 柴胡半夏汤加味联合艾司奥美拉唑对气郁痰阻型胃食管反流病的临床疗效观察[D]: [硕士学位论文]. 武汉: 湖北中医药大学, 2024.
[17] 王杰, 丁楚, 孙永顺. 中医治疗胃食管反流病的临床研究进展[J]. 中国中医急症, 2023, 32(3): 535-539.
[18] 叶钒, 刘艳, 谭丹丹, 等. 基于胃食管反流病的中医治疗临床效果研究[J]. 医学论坛, 2025, 7(8): 164-166.